NDC 25021-791

LACOSAMIDE

Lacosamide

LACOSAMIDE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Lacosamide.

Product ID25021-791_4cbdcccf-ea0b-4ba4-82ac-916374405730
NDC25021-791
Product TypeHuman Prescription Drug
Proprietary NameLACOSAMIDE
Generic NameLacosamide
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-03-17
Marketing CategoryANDA /
Application NumberANDA214301
Labeler NameSagent Pharmaceuticals
Substance NameLACOSAMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 25021-791-20

10 VIAL, GLASS in 1 CARTON (25021-791-20) > 20 mL in 1 VIAL, GLASS
Marketing Start Date2022-03-17
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LACOSAMIDE" or generic name "Lacosamide"

NDCBrand NameGeneric Name
0121-0992LacosamideLacosamide
0121-1984LacosamideLacosamide
0121-2976LacosamideLacosamide
0121-3968LacosamideLacosamide
63850-0055LacosamideLacosamide
63850-0053LacosamideLacosamide
63850-0054LacosamideLacosamide
63850-0056LacosamideLacosamide
65162-912LacosamideLacosamide
0131-1810Vimpatlacosamide
0131-2470Vimpatlacosamide
0131-2477Vimpatlacosamide
0131-2478Vimpatlacosamide
0131-2479Vimpatlacosamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.